Healthcare Economist January 26, 2026
President Trump unveiled “The Great Healthcare Plan” on January 15, 2026, calling on Congress to reduce prescription drug prices, lower insurance premiums, and increase healthcare price transparency. The plan proposes four main components:
- codifying Most-Favored-Nation (MFN) drug pricing agreements that the administration has negotiated with 16 pharmaceutical manufacturers, targeting prices at the lowest international levels;
- Redirecting Affordable Care Act (ACA) exchange plan subsidies as direct payments to consumers via Health Savings Accounts (HSA) rather than to insurance companies;
- Restoring Cost-Sharing Reduction (CSR) funding for ACA plans; and
- Mandating insurance and provider price transparency, including claims denial rates and medical loss ratios.
Some more details are available at this fact sheet.
The fiscal impact remains highly uncertain. The Committee...







